Biojunkie ApS: Financial statements 2023
CVR: 41058404
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Biojunkie ApS (CVR 41058404) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 21,891 and a net result of DKK -59,477 compared with DKK -16,239 the year before. The profit margin was -271.7%. Equity in the 2023 report amounted to DKK 23,284. The solvency ratio was 28.3%.
- Revenue
- DKK 21,891
- Gross Profit
- DKK 21,891
- Profit/Loss
- DKK -59,477
- Equity
- DKK 23,284
- Total Assets
- DKK 82,414
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 22 t. | 22 t. | -59 t. | 23 t. | - |
| 2022 | - | - | -16 t. | 83 t. | - |
| 2021 | - | - | -14 t. | 100 t. | - |
| 2020 | - | - | 0 | 100 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of December 31, 2023, Allan Bach Sørensen has left the board of directors of Biojunkie ApS.
Biojunkie ApS has published its annual report for 2022. The net result was DKK -16,239.
About Biojunkie ApS
Biojunkie ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2019. The company is registered under the industry Detailhandel med kosmetikvarer og toiletartikler. The management consists of Rozamistica Lugangiza Pedersen. The board consists of Rozamistica Lugangiza Pedersen (chair). The company is owned by Tox Regulatory Advisor Aps. In 2025, the company reported a gross profit of DKK -41,096 and a net result of DKK -44,696 compared with DKK -153,165 the year before. Equity in the 2025 report amounted to DKK -188,000.